Figure 3.

Modulation of BALF neutrophilia by a single OVA challenge and administration of the 5A apoA-I mimetic peptide in OVA-challenged apoA-I^−/− mice. (A) Number of total inflammatory cells and inflammatory cell types in BALF 24 hours after a single OVA challenge (n = 3 mice). (B) Number of total inflammatory cells and inflammatory cell types in BALF from mice that had received an intranasal administration of either the 5A apolipoprotein A-I mimetic peptide (5A) or an irrelevant control peptide (control), concurrent with multiple daily saline or OVA challenges, 5 days per week for 4 weeks, after intraperitoneal sensitization with OVA plus aluminum hydroxide (n = 10 mice, *P < 0.01). NS, no significance.